The Office of Clinical Research (OCR) supports the high-quality programs of clinical research at Memorial Sloan-Kettering Cancer Center through central management, standardized practice, manufacturing quality assurance and oversight to our clinical research programs. The OCR strives to ensure that clinical research policies and procedures adhere to existing research standards as well as federal regulations.
The OCR is composed of the following divisions:
OCR Operations
- Administration
- Research Non-Billable (RNB) Office
- Education and Certification
- Minority Serving Institutions (MSI)
- Clinical Research at the Regional Networks
- Websites
- Research Support Services (RSS)
- Long-Term Followup (LTFU)
- Multicenter Trial Group (MCTG)
Protocol Development Office (PDO)
- Investigational New Drug (IND) Office
- Research Council (RC)
- Human Biospecimen Utilization Committee (HBUC)
- OCR Protocol Review
Clinical Research Informatics (CRI)
- Data Management Resource (DMR)
- Protocol Participant Registration (PPR)
- Clinical Trials.gov Registration
Clinical Research Quality Assurance (CRQA)
- Monitoring and Auditing
- Data and Safety Monitoring Committee (DSMC)
- Data and Safety Monitoring Board (DSMB)
- Therapeutic Response Review Committee (TRRC)
Investigational Products (IP) Division
- Translational Research
- Manufacturing QA
Institutional Review Board/Privacy Board (IRB/PB) Office
- Serious Adverse Event (SAE) Office